News Releases - Insmed Incorporated Investor Relations
https://investor.insmed.com/2022-02-17-Insmed-Reports-Fourth-Quarter-and-Full-Year-2021-Financial-Results-and-Provides-Business-and-Pipeline-Update
WEBFeb 17, 2022 · Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States , Europe , and Japan to treat a chronic, debilitating lung disease.
DA: 61 PA: 48 MOZ Rank: 37 Up or Down: Up